Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
4.110
+0.050 (1.23%)
At close: Jan 23, 2026, 4:00 PM EST
4.080
-0.030 (-0.73%)
After-hours: Jan 23, 2026, 7:53 PM EST

Lisata Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Jan '26 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
362522205028
Upgrade
Market Cap Growth
15.82%12.58%11.75%-60.48%81.39%6.25%
Upgrade
Enterprise Value
17-11-32-55-50-12
Upgrade
Last Close Price
4.112.982.732.5312.6221.45
Upgrade
PS Ratio
32.9825.02----
Upgrade
PB Ratio
2.070.850.460.300.550.86
Upgrade
P/TBV Ratio
2.100.850.460.300.550.85
Upgrade
EV/Sales Ratio
16.13-----
Upgrade
Debt / Equity Ratio
-0.010.010.010.010.02
Upgrade
Asset Turnover
0.040.02----
Upgrade
Quick Ratio
4.425.897.6710.9621.009.86
Upgrade
Current Ratio
4.726.168.1811.2621.2710.08
Upgrade
Return on Equity (ROE)
-72.17%-51.77%-36.49%-68.50%-44.21%-30.84%
Upgrade
Return on Assets (ROA)
-41.86%-31.23%-25.16%-20.00%-27.30%-37.89%
Upgrade
Return on Capital Employed (ROCE)
-116.80%-76.20%-53.40%-40.80%-31.40%-58.90%
Upgrade
Earnings Yield
-50.32%-79.89%-93.79%-272.69%-54.59%-29.38%
Upgrade
FCF Yield
-47.60%-77.37%-90.15%-107.90%-44.33%-31.88%
Upgrade
Buyback Yield / Dilution
-3.87%-3.17%-55.85%-40.46%-258.29%-49.54%
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q